Reply to "MASLD fibrosis stage F3 is morphologically and transcriptomically diverse: implications for assessing therapeutic response" by Chaoyi Li, Quan H. Nguyen, Katharine Irvine, Elizabeth E. Powell, Andrew Clouston. — SciRadar